Unexpectedly, inhibition of the LSD1 demethylase activity with GSK-LSD1 in SSc fibroblasts did not alter NID production, pSMAD3, α-SMA, or β-catenin at the protein level (Figure 3D,E). The gene discussed is NID1; the disease is systemic sclerosis.